+91 7986995600
seclislabs@gmail.com
Contact Us
Home › Diabetic Therapy › METSIFER™ G1
Diabetic Therapy

METSIFERâ„¢ G1

Glimepiride 1mg + Metformin HCl Prolonged Release 500mg

Dosage Form Tablets (bi-layered)
Packing 10x15 Blister
MRP ₹1275
Prescribed By Diabetologist, Endocrinologist, General Physician, Internal Medicine, Family Medicine

Quick Facts

Form Bi-Layered Tablets
Pack 10×15 Blister
MRP ₹1275
Prescribed By Diabetologist, Endocrinologist, General Physician

Key Benefits

01
Dual mechanism for better blood sugar control.
02
Prolonged-release Metformin reduces GI side effects.
03
Glimepiride 1mg — a lower dose for initiating combination therapy.
04
Convenient bi-layered tablet.

Mechanism of Action

Glimepiride stimulates insulin release from the pancreas. Metformin reduces liver glucose output and improves insulin sensitivity. Together they provide complementary blood sugar control with a lower insulin dose needed.

Indications

Type 2 diabetes mellitus requiring combination sulphonylurea and biguanide therapy.

Dosage & Administration

Take as prescribed by your doctor or healthcare professional. Do not self-medicate.

Why METSIFERâ„¢ G1?

METSIFER G1 is a well-established combination for Type 2 diabetes, combining Glimepiride's insulin-stimulating action with Metformin's insulin-sensitising effect for better overall glycaemic control.

Interested in franchising METSIFERâ„¢ G1?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top